In silico study of mangostin compounds and its derivatives as inhibitors of α-glucosidase enzymes for anti-diabetic studies
Diabetes is a chronic disease with a high mortality rate worldwide and can cause other diseases such as kidney damage, narrowing of blood vessels, and heart disease. The concomitant use of drugs such as metformin, sulfonylurea, miglitol, and acarbose may cause side effects with long-term administrat...
Saved in:
| Main Authors: | Maulana, Ahmad Fariz, Sriwidodo, Sriwidodo, Rukayadi, Yaya, Maksum, Iman Permana |
|---|---|
| Format: | Article |
| Published: |
MDPI AG
2022
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro and in silico evaluations of diarylpentanoid series as a-glucosidase inhibitor
by: Leong, Sze Wei, et al.
Published: (2018) -
Synthesis of diarylpentadienones and pyrazoline derivatives as potential α-glucosidase inhibitor and their antioxidant activities
by: Adam, Faruk Auwal, et al.
Published: (2023) -
α-Glucosidase inhibitors: consistency of: in silico docking data with in vitro inhibitory data and inhibitory effect prediction of quercetin derivatives
by: Zhu, Jianzhong, et al.
Published: (2019) -
Alpha-mangostin and beta-mangostin from Cratoxylum laucum.
by: Ee, Gwendoline Cheng Lian, et al.
Published: (2011) -
Cloning and Expression of a Thermostable-α Glucosidase
by: A. Mohamed, Rauda
Published: (2010)
